Beijing, China

Xianyong Liu


 

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2012-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Xianyong Liu: Innovator in Immunology and Vaccine Development

Introduction

Xianyong Liu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of immunology, particularly in the development of innovative vaccine technologies. With a total of 2 patents, Liu's work focuses on enhancing immune responses through novel approaches.

Latest Patents

Liu's latest patents include the development of a porcine CD28 receptor and its application. This invention provides a porcine CD28 receptor molecule, which is a protein consisting of an amino acid sequence represented by SEQ ID NO:2. The receptor can also be derived from this sequence through substitutions, deletions, or additions of amino acids while maintaining equivalent activity. Additionally, Liu has developed a gene for encoding the porcine CD28 receptor, with its nucleotide sequence shown as SEQ ID NO:1. This innovation enhances T cell activation, proliferation, and cytokine secretion when stimulated by an antigen, thereby improving the acquired immune response and vaccine efficacy.

Another significant patent involves the use of coccidian as a vaccine live vector. This invention presents a live vaccine utilizing transgenic coccidian capable of expressing exogenous proteins. The coccidian vector live vaccine can induce protective humoral and cellular immune responses, including mucosal immunity, while ensuring high biological safety and stability without generating immune tolerance.

Career Highlights

Throughout his career, Xianyong Liu has worked with notable organizations, including the Zhonghao Chenguang Research Institute of Chemical Industry Company Limited. His expertise in immunology and vaccine development has positioned him as a key figure in advancing vaccine technologies.

Collaborations

Liu has collaborated with esteemed colleagues such as Xun Suo and Xiaojia Wang. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Xianyong Liu's contributions to immunology and vaccine development are noteworthy. His innovative patents reflect his commitment to enhancing immune responses and improving vaccine efficacy. Liu's work continues to influence the field and pave the way for future advancements in vaccine technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…